一种关键的致癌性长非编码RNA,调整了固体恶性瘤的特征
Monica M Rostom1, Alaa A Rashwan2, Christina D Sotiropoulou3
1Pharmacology and Toxicology Department, Faculty of Pharmacy and Biotechnology, German University in Cairo, 11835, Cairo, Egypt.
Translational oncology
|February 27, 2025
概括
长非编码RNA (lncRNA) MIAT是固体瘤中的致癌调节剂,影响生长,入侵和转移. MIAT显示出作为癌症生物标志物和治疗点的潜力.
科学领域:
- 分子生物学分子生物学
- 基因组学就是基因组学.
- 在瘤学瘤学.
背景情况:
- 长非编码RNAs (lncRNAs) 是细胞过程中的关键调节者,挑战细胞的长非编码RNAs.
- 非编码DNA构成了人类基因组的很大一部分,并与癌症的发展有关.
- lncRNAs在基因调节和染色体动力学中起着至关重要的作用.
研究的目的:
- 审查心肌梗塞相关转录 (MIAT) 在固体恶性瘤中的复杂作用.
- 探索MIAT表达与癌症患者临床病理特征之间的相关性.
- 概述MIAT的生物学功能,机制,临床含义和癌症发生中的治疗策略.
主要方法:
- 关于MIAT在各种癌症中的研究的文献综述.
- 分析MIAT的致癌功能,包括生长,入侵,转移和细胞死亡抵抗.
- 检查MIAT与临床病理特征的相关性.
主要成果:
- 在许多恶性瘤中,MIAT充当瘤调节剂.
- MIAT影响癌细胞的生长,入侵,转移和耐药性.
- MIAT表达与癌症患者的临床病理特征相关.
结论:
- MIAT是一种显著的致癌性 lncRNA,具有作为癌症生物标志物和治疗点的潜力.
- 了解MIAT在致癌过程中的作用对于开发向疗法至关重要.
- 对针对MIAT的治疗方法进行进一步的研究是有必要的.
关键词:
癌症 癌症 癌症 癌症标志性的标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标志标这是一个LncRNARNA.长长的非编码RNA.这就是MIAT MIAT.这是一种瘤性致癌症.固体恶性瘤是一种固体恶性瘤.相关概念视频
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


